Effects of resistance training frequency on physical functioning and quality of life in prostate cancer survivors: A pilot randomized controlled trial

Prostate Cancer and Prostatic Diseases

Volumn 18, Issue 3, 2015, Pages 281-287

  Norris, M K ^a   Bell, G J ^a   North, S ^a   Courneya, K S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTIONALITY; HAPPINESS; HUMAN; MALE; MENTAL FUNCTION; MENTAL HEALTH; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PERCEIVED STRESS SCALE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SOCIAL PSYCHOLOGY; TREND STUDY; VITALITY; ALBERTA; CLINICAL TRIAL; COMORBIDITY; FITNESS; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; PSYCHOLOGY; REGISTER; RISK FACTOR; SURVIVOR;

AGED; ALBERTA; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PHYSICAL FITNESS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; REGISTRIES; RESISTANCE TRAINING; RISK FACTORS; SURVIVORS;

EID: 84939265148     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2015.28     Document Type: Article

References (50)

1. Canadian Cancer Society's Steering Committee on Cancer S. Canadian Cancer Statistics 2014. Canadian Cancer Society: Toronto, ON, 2014.
2. Bosco C, Bosnyak Z, Malmberg A, Adolfsson J, Keating NL, Van Hemelrijck M. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis. Eur Urol 2014; pii: S0302-S2838.
3. Crawford ED, Moul JW. ADT risks and side effects in advanced prostate cancer: cardiovascular and acute renal injury. Oncology (Williston Park, NY) 2015; 29: 112-126.
4. Nguyen PL, Alibhai SMH, Basaria S, D'Amico AV, Kantoff PW, Keating NL, et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 2014; 67: 825-836.
5. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term healthrelated quality of life after primary treatment for localized prostate cancer: results from the CaPSURE Registry. Eur Urol 2014; pii: S0302-S2838.
6. Rhee H, Gunter JH, Heathcote P, Ho K, Stricker P, Corcoran NM, et al. Adverse effects of androgen deprivation therapy in prostate cancer and their management. BJU Int 2014; 115: 3-13.
7. Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol 2014; 32: 335-346.
8. Keogh JWL, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manage 2012; 43: 96-110.
9. Strasser B, Steindorf K, Wiskemann J, Ulrich CM. Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 2013; 45: 2080-2090.
10. Hardee JP, Porter RR, Sui X, Archer E, Lee IM, Lavie CJ, et al. The effect of resistance exercise on all-cause mortality in cancer survivors. Mayo Clin Proc 2014; 89: 1108-1115.
11. Bourke L, Gilbert S, Hooper R, Steed LA, Joshi M, Catto JW, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014; 65: 865-872.
12. Galvao D, Nosaka K, Taaffe D, Spry N, Kristjanson L, McGuigan M, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 2006; 38: 2045-2052.
13. Galvao DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014; 65: 856-864.
14. Galvaõ DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010; 28: 340-347.
15. Park SW, Kim TN, Nam JK, Ha HK, Shin DG, Lee W, et al. Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled study. Urology 2012; 80: 299-305.
16. Cormie P, Galvaõ DA, Spry N, Joseph D, Chee R, Taaffe DR, et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int 2015; 115: 256-266.
17. Alberga AS, Segal RJ, Reid RD, Scott CG, Sigal RJ, Khandwala F, et al. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer. Support Care Cancer 2012; 20: 971-981.
18. Keats MR, Culos-Reed S, Courneya KS, McBride M. Understanding physical activity in adolescent cancer survivors: an application of the theory of planned behavior. Psychooncology 2007; 16: 448-457.
19. Hansen PA, Dechet CB, Porucznik CA, LaStayo PC. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study. Phys Med Rehabil 2009; 1: 1019-1024.
20. Hanson ED, Sheaff AK, Sood S, Ma L, Francis JD, Goldberg AP, et al. Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy. J Gerontol Ser A 2013; 68: 490-498.
21. Santa Mina D, Ritvo P, Matthew AG, Rampersad A, Stein H, Cheung AM, et al. Group exercise versus personal training for prostate cancer patients: a pilot randomized trial. J Cancer Ther 2012; 3.
22. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653-1659.
23. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009; 27: 344-351.
24. Schmitz K, Courneya K, Matthews C, Demark-Wahnefried W, Galvao D, Pinto B, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010; 42: 1409-1426.
25. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012; 62: 242-274.
26. Braith RW, Graves JE, Pollock ML, Leggett SL, Carpenter DM, Colvin AB. Comparison of 2 vs 3 days/week of variable resistance training during 10-and 18-week programs. Int J Sports Med 1989; 10: 450-454.
27. Candow DG, Burke DG. Effect of short-term equal-volume resistance training with different workout frequency on muscle mass and strength in untrained men and women. J Strength Cond Res 2007; 21: 204-207.
28. Farinatti PT, Geraldes AA, Bottaro MF, Lima MV, Albuquerque RB, Fleck SJ. Effects of different resistance training frequencies on the muscle strength and functional performance of active women older than 60 years. J Strength Cond Res 2013; 27: 2225-2234.
29. Murlasits Z, Reed J, Wells K. Effect of resistance training frequency on physiological adaptations in older adults. J Exerc Sci Fit 2012; 10: 28-32.
30. Nakamura Y, Tanaka K, Yabushita N, Sakai T, Shigematsu R. Effects of exercise frequency on functional fitness in older adult women. Arch Gerontol Geriatr 2007; 44: 163-173.
31. Taaffe D, Duret C, Wheeler S, Marcus R. Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults. J Am Geriatr Soc 1999; 47: 1208-1214.
32. Gillam GM. Effects of frequency of weight training on muscle strength enhancement. J Sports Med Phys Fitness 1981; 21: 432-436.
33. Courneya KS. Physical activity and cancer survivorship: a simple framework for a complex field. Exerc Sport Sci Rev 2014; 42: 102-109.
34. Strasser B, Steindorf K, Wiskemann J, Ulrich C. Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 2013; 45: 2080-2090.
35. Mayhew JL, Ball TE, Arnold MD, Bowen JC. Relative muscular endurance performance as a predictor of bench press strength in college men and women. J Strength Cond Res 1992; 6: 200-206.
36. Rikli R, Jones C. Development and validation of a functional fitness test for community-residing older adults. J Aging Phys Activ 1999; 7: 129-161.
37. Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME, et al. User's Manual for the SF-36v2 Health Survey. Quality Metric: Lincoln, RI, 2007.
38. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapyprostate instrument. Urology 1997; 50: 920-928.
39. Yellen S, Cella D, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13: 63-74.
40. Rosenberg M. Society and the Adolescent Self Image. University Press: Princeton, NJ, 1965.
41. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994; 10: 77-84.
42. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory, 1970.
43. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385-396.
44. Fordyce MW. A review of research on the happiness measures: a sixty second index of happiness and mental health. Soc Indic Res 1988; 20: 355-381.
45. Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Sympt Manage 2004; 27: 140-148.
46. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
47. Godin G, Shephard R. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985; 10: 141-146.
48. Jacobs DR Jr, Ainsworth BE, Hartman TJ, Leon AS. A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc 1993; 25: 81-91.
49. Galvao DA, Taaffe DR, Spry N, Joseph D, Turner D, Newton RU. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation. Prostate Cancer Prost Dis 2009; 12: 198-203.
50. Galvao D, Spry N, Taaffe D, Newton R, Stanley J, Shannon T, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int 2008; 102: 44-47.